TrialRheumatology (Oxford, England)2025

Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.

Duvuru Geetha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.